Share on StockTwits

Merit Medical Systems (NASDAQ:MMSI) is scheduled to issue its Q413 quarterly earnings data on Monday, February 24th. Analysts expect the company to announce earnings of $0.19 per share and revenue of $117.26 million for the quarter. Parties interested in participating in the company’s conference call can do so using this link.

Shares of Merit Medical Systems (NASDAQ:MMSI) opened at 15.22 on Friday. Merit Medical Systems has a one year low of $9.15 and a one year high of $17.08. The stock’s 50-day moving average is $14.84 and its 200-day moving average is $14.48. The company has a market cap of $650.6 million and a P/E ratio of 61.00.

MMSI has been the subject of a number of recent research reports. Analysts at Zacks downgraded shares of Merit Medical Systems from an “outperform” rating to a “neutral” rating in a research note on Tuesday, December 24th. They now have a $17.80 price target on the stock. Analysts at Noble Financial initiated coverage on shares of Merit Medical Systems in a research note on Tuesday, December 10th. They set a “buy” rating and a $19.00 price target on the stock. Three analysts have rated the stock with a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $15.70.

Merit Medical Systems, Inc (NASDAQ:MMSI) designs, develops, manufactures and markets medical devices used in interventional and diagnostic procedures.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.